According to CapBio's announcement, the company's share repurchase plan has been completed. The actual repurchase period is from July 28, 2026 to October 20, 2026. A total of 257.103 million shares were repurchased, accounting for 3.98% of the company's total share capital. The highest transaction price was 6.32 yuan/share, the lowest transaction price was 5.35 yuan/share, and the total transaction amount was 150 million yuan. This repurchase complies with relevant plans and regulations, will not have a significant adverse impact on the company's operations, etc., and will not lead to a change in control. Shares that have already been repurchased will be stored in a special repurchase account. After 12 months, they will be sold using centralized bidding. The unsold portion will be cancelled according to law within 3 years.

According to CapBio's announcement, the company's share repurchase plan has been completed. The actual repurchase period is from July 28, 2026 to October 20, 2026. A total of 257.103 million shares were repurchased, accounting for 3.98% of the company's total share capital. The highest transaction price was 6.32 yuan/share, the lowest transaction price was 5.35 yuan/share, and the total transaction amount was 150 million yuan. This repurchase complies with relevant plans and regulations, will not have a significant adverse impact on the company's operations, etc., and will not lead to a change in control. Shares that have already been repurchased will be stored in a special repurchase account. After 12 months, they will be sold using centralized bidding. The unsold portion will be cancelled according to law within 3 years.